Anxiety in Children With Attention-Deficit/Hyperactivity Disorder
- Emma Sciberras, DPsycha,b,
- Kate Lycett, BA, GDipPsycha,c,
- Daryl Efron, FRACP, MDa,b,c,
- Fiona Mensah, PhDa,d,
- Bibi Gerner, MPsycha, and
- Harriet Hiscock, FRACP, MDa,b,c
- aCommunity Child Health, Murdoch Childrens Research Institute, Parkville, Australia;
- bThe Royal Children’s Hospital, Parkville, Australia;
- cDepartment of Paediatrics, University of Melbourne, Parkville, Australia;
- dClinical Epidemiology and Biostatistics Unit, Murdoch Childrens Research Institute, The Royal Children’s Hospital, Parkville, Australia
OBJECTIVES: Although anxiety is common in children with attention-deficit/hyperactivity disorder (ADHD), it is unclear how anxiety influences the lives of these children. This study examined the association between anxiety comorbidities and functioning by comparing children with ADHD and no, 1, or ≥2 anxiety comorbidities. Differential associations were examined by current ADHD presentation (subtype).
METHODS: Children with diagnostically confirmed ADHD (N = 392; 5–13 years) were recruited via 21 pediatrician practices across Victoria, Australia. Anxiety was assessed by using the Anxiety Disorders Interview Schedule for Children—IV. Functional measures included parent-reported: quality of life (QoL; Pediatric Quality of Life Inventory 4.0), behavior and peer problems (Strengths and Difficulties Questionnaire), daily functioning (Daily Parent Rating of Evening and Morning Behavior), and school attendance. Teacher-reported behavior and peer problems (Strengths and Difficulties Questionnaire) were also examined. Linear and logistic regression controlled for ADHD severity, medication use, comorbidities, and demographic factors.
RESULTS: Children with ≥2 anxiety comorbidities (n = 143; 39%) had poorer QoL (effect size: –0.8) and more difficulties with behavior (effect size: 0.4) and daily functioning (effect size: 0.3) than children without anxiety (n = 132; 36%). Poorer functioning was not observed for children with 1 anxiety comorbidity (n = 95; 26%). Two or more anxiety comorbidities were associated with poorer functioning for children with both ADHD-Inattentive and ADHD-Combined presentation.
CONCLUSIONS: Children with ADHD demonstrate poorer QoL, daily functioning and behavior when ≥2 anxiety comorbidities are present. Future research should examine whether treating anxiety in children with ADHD improves functional outcomes.
- attention-deficit/hyperactivity disorder
- anxiety disorders
- internalizing disorders
- quality of life
- ADHD —
- attention-deficit/hyperactivity disorder
- ADHD-C —
- ADHD Combined presentation
- ADHD-I —
- ADHD Inattentive presentation
- ADIS-C —
- Anxiety Disorders Interview Schedule for Children/Parent Version IV
- ASD —
- Autism Spectrum Disorder
- DSM-IV —
- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
- ES —
- effect size
- QoL —
- quality of life
- SEIFA —
- Socioeconomic Indexes for Areas
What’s Known on This Subject:
Up to 50% of children with attention-deficit/hyperactivity disorder (ADHD) meet criteria for a comorbid anxiety disorder. Despite the high prevalence of anxiety in these children, the impact of anxiety on the lives of children with ADHD has been largely overlooked.
What This Study Adds:
Presence of ≥2 anxiety comorbidities in children with ADHD was associated with poorer child quality of life, daily functioning, and behavior. Multiple anxiety comorbidities were associated with poorer functioning for children with both ADHD-Inattentive and ADHD-Combined presentation.
At least 60% of children with attention-deficit/hyperactivity disorder (ADHD) meet criteria for ≥1 comorbid disorders (eg, externalizing, mood, autism spectrum [ASD], and learning disorders).1 Although externalizing comorbidities have been widely studied in children with ADHD, anxiety has received less attention. Approximately 25% to 50% of children with ADHD suffer from at least 1 anxiety disorder, including separation, social, and generalized anxiety.2,3 Yet the impact of anxiety on the lives of children with ADHD remains poorly understood. If anxiety adversely affects functioning, then the management of anxiety should be prioritized in treatment.
Although previous research has suggested that children with ADHD and anxiety are less impulsive,4,5 studies have demonstrated that these children have more attentional4,6 and broader cognitive and executive functioning difficulties7 than those with ADHD alone. It is possible that exacerbation of executive functioning difficulties for children with ADHD and anxiety, in combination with the avoidance and negative thought patterns associated with anxiety, may have a negative impact on functioning for these children. Research examining the impact of anxiety in ADHD has largely focused on social function. Although anxiety has been shown to exacerbate social problems for children with ADHD,6,8–11 these findings are not always supported.12–14 Mixed findings may be due to methodologic limitations, including single clinical samples,8 broad participant age range,6,12 and small samples.6,10 Although it is suspected that anxiety in children with ADHD would be associated with poorer quality of life (QoL) and daily functioning, research has yet to examine this. Furthermore, despite children with ADHD-Combined (ADHD-C) and ADHD-Inattentive (ADHD-I) presentation having similar levels of anxiety,15 it is unknown whether the association between anxiety and function is similar for ADHD-C versus ADHD-I.
Previous research has not fully accounted for factors that may confound the relationship between anxiety and function including ADHD symptom severity, externalizing and mood disorders, and ASD, which is problematic given that these comorbidities influence functioning1 and commonly co-occur with anxiety.16,17 Furthermore, studies have not accounted for the impact of having multiple anxiety disorders, a common occurrence for children with ADHD.18,19 It is unknown whether functioning is only comprised when more pervasive levels of anxiety are present. In the general population, the presence of multiple anxiety disorders, in particular, is associated with multiple adverse outcomes.20 Although parents of children with ADHD and anxiety have increased psychiatric symptoms,21–23 this has not been taken into account when examining the impact of anxiety in these children.
Therefore, in a large sample of children with ADHD, we aimed to examine
differences in functioning (QoL, peer functioning, behavior, daily functioning, school attendance) between children without anxiety and those with 1 anxiety comorbidity and ≥2 anxiety comorbidities; and
whether anxiety is associated with poorer functioning in children with ADHD-C and ADHD-I.
It was hypothesized that children with ADHD and anxiety (both 1 or ≥2 anxiety comorbidities) would have poorer functioning across all domains compared with those without anxiety. No hypothesis was formed for the second aim given the paucity of previous research.
Design and Setting
Participants were recruited via 21 public and private pediatric practices across Victoria, Australia, for 2 harmonized ADHD studies: (1) a randomized controlled trial of a behavioral sleep intervention24 and (2) a comparable cohort with no/mild sleep problems.25 This study uses baseline data from these two studies. Ethics approval was obtained by the Royal Children’s Hospital (31193; 30033) and the Victorian Department of Education and Early Childhood Development (2011_001307; 2010_000573).
Eligibility and Recruitment
Participating pediatricians (N = 50) mailed invitation letters to children with ADHD aged 5 to 12 years seen in the past year. An opt-out approach was used in which families contacted the research team if they did not want to hear about the study. Parents who did not opt out were telephoned to assess eligibility and interest in participating.
To be eligible, children needed to have been diagnosed with ADHD by their pediatrician and meet full Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for ADHD. DSM-IV symptom criteria was assessed by using the parent-reported 18-item ADHD Rating Scale—IV26; items directly reflect DSM-IV symptom content, and the measure has excellent reliability and validity.26 Parents reported on their child’s unmedicated behavior. Items are rated on a 4-point scale from “never” (0) to “very often” (4). Symptoms rated “often” and “very often” are scored 1 (symptom present), and symptoms rated “never” and “sometimes” are scored 0 (symptom absent). Parents needed to endorse at least 6 of 9 symptoms as present in either symptom domain to be eligible. Study-designed questions assessed additional DSM-IV criteria including symptom duration of ≥6 months, age of onset before 7 years, and cross-situational impairment. Children were classified as ADHD-C if ≥6 symptoms were endorsed in both symptom domains and were classified as ADHD-I or ADHD hyperactive/impulsive type if ≥6 symptoms were only endorsed in 1 of the respective domains. Children needed to be aged 5 to 13 years at the time of recruitment, and those in the randomized controlled trial needed to have a parent-reported moderate/severe sleep problem and meet criteria for ≥1 sleep disorder27 to be eligible. Children in the cohort study needed to have no/mild sleep problems.
Exclusion criteria included (1) insufficient English to participate, (2) receiving specialized sleep assistance from a psychologist or sleep clinic, and (3) child having a serious medical condition (eg, cerebral palsy), intellectual disability, or suspected obstructive sleep apnea.
Eligible families were mailed an information sheet, consent form, and survey. Families were enrolled upon receipt of the completed consent form and survey. Enrolled parents were then telephoned to complete a diagnostic interview, and teachers were mailed a consent form and survey if parental consent was provided.
Anxiety was measured by using the Anxiety Disorders Interview Schedule for Children/Parent Version IV (ADIS-C), a semistructured diagnostic interview assessing DSM-IV disorders.28 Separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, posttraumatic stress disorder, and obsessive-compulsive disorder were assessed. To screen positive for an anxiety disorder, children needed to meet symptom criteria and be experiencing significant impairment (rating of ≥4 of 8). Interviewers held a minimum fourth-year degree in psychology, were extensively trained, and were blind to previous anxiety diagnosis. Cross-coding indicated good reliability for obsessive-compulsive disorder (k = 0.69; P < .001) and excellent reliability for other categories (k = 0.83–1.0; P < .001). In the parent survey, we also asked whether the child had been previously diagnosed with an anxiety disorder.
QoL was assessed by using the 23-item Pediatric Quality of Life Inventory 4.0—parent proxy report.29 Items are rated on a 5-point scale from “never” (1) to “almost always” (5) based on the child’s problems over the past month. We report the 15-item psychosocial QoL score (α = 0.80), with scores ranging from 0 to 100 (higher scores indicate better QoL).
Behavior and peer problems were measured by using the parent- and teacher-reported Strengths and Difficulties Questionnaire.30 Items are rated on a 3-point scale from “not true” (0) to “certainly true” (2). Behavior and peer problems were assessed by using the 20-item total problems scale (α = 0.63) and 5-item peer problems subscale (α = 0.71), respectively.
Daily functioning was measured by using the Daily Parent Rating of Evening and Morning Behavior,31 an 11-item parent-reported measure of morning (eg, getting up and out of bed) and evening (eg, completing homework) behavior over the previous 4 weeks (α = 0.83). Items are rated on a 4-point scale from “never” (0) to “a lot” (3), with higher scores indicating worse functioning.
Child school attendance was measured by parent-report of the number of days their child had missed or been late for school over the preceding 3 months.32
Parent mental health was assessed by using the Depression, Anxiety and Stress Scales total score,33 a 21-item measure of adult mental health, with higher scores indicating poorer mental health.
A priori confounders included child age and gender, ADHD medication use (yes/no), ADHD symptom severity (ADHD Rating Scale—IV, total score), mood disorder (yes/no: ADIS-C), externalizing disorder (yes/no: ADIS-C), ASD (yes/no: parent-report of a previous diagnosis), parent age, parent high school completion (yes/no), and neighborhood socioeconomic disadvantage score measured by the census-based Socioeconomic Indexes for Areas Disadvantage Index (SEIFA) for the child’s postcode of residence (mean 1000, SD 100; higher scores reflect less disadvantage).34
Summary statistics were used to describe sample characteristics, outcome variables, and anxiety comorbidities. Children were classified into 1 of 3 groups: (1) no anxiety, (2) 1 anxiety comorbidity, or (3) ≥2 anxiety comorbidities. χ2 tests and analysis of variance were used to compare sample characteristics across groups.
Linear regression was used to compare the mean difference on each continuous outcome for children with one anxiety comorbidity and children with ≥2 anxiety comorbidities, compared with those without anxiety (aim 1). Results are presented as effect sizes, which were calculated by standardizing outcome variables to have a mean of 0 and a SD of 1. Analyses were rerun adjusting for a priori confounding variables. Sensitivity analyses were conducted adjusting for parent mental health symptoms.
To examine whether the association between anxiety and functioning was similar for children with ADHD-C and ADHD-I, adjusted analyses were rerun stratifying by ADHD presentation (aim 2). We also conducted formal tests of interaction to determine differences in the association between anxiety and functioning by ADHD presentation. We adjusted for all variables described previously except for ADHD symptom severity given that this variable defines ADHD presentation groupings. Analyses were conducted by using Stata 13.0.
We distributed invitation letters to 1349 families, and of these, 522 were not assessed for eligibility: 233 were not interested, 192 could not be contacted, 9 had insufficient English to participate, and 89 were outside of the study age range. Of the 827 families assessed for eligibility, 561 were eligible. The main reasons for ineligibility included not meeting ADHD DSM-IV criteria (n = 99) and having an intellectual disability (n = 53).
70% (n = 392) of eligible families participated: 244 children with moderate/severe and 148 with no/mild sleep problems. There were no differences in child gender or age or SEIFA scores between participants and nonparticipants. Participants were analyzed if they had complete ADIS-C data (n = 370; 94%). Teacher data were available for 298 children (76%). Children with teacher data were slightly younger (mean 10.0 years vs 10.7 years); no other differences were detected.
Thirty-six percent (n = 132) had no anxiety comorbidity; 26% (n = 95) had 1 anxiety comorbidity, and 39% (n = 143) had ≥2 anxiety comorbidities. Social phobia was the most common (n = 177; 48%), followed by generalized anxiety (n = 125; 34%), separation anxiety (n = 119; 32%), obsessive compulsive (n = 31; 8%), posttraumatic stress (n = 22; 6%), and panic (n = 9; 2%) disorders. All participants had seen their pediatrician in the past 12 months, and 85% were taking medication for ADHD. Children with multiple anxiety comorbidities were older; were more likely to have comorbidities and moderate/severe sleep problems; had more severe ADHD; were more likely to have ADHD-C; and had parents with elevated mental health symptoms (Table 1). Fifteen percent (n = 14) of children with 1 anxiety comorbidity and 32% (n = 46) with multiple anxiety comorbidities had been previously been diagnosed with an anxiety disorder.
Association Between Anxiety and Functioning
Table 2 presents the mean scores and standard deviations for outcome variables by anxiety group. In unadjusted analyses (Table 3), children with multiple anxiety comorbidities had poorer parent-reported QoL (effect size [ES]: –1.1) and more difficulties in behavior (ES: 0.9), peer functioning (ES: 0.5), and daily functioning (ES: 0.7). Differences in teacher-reported outcomes were not evident, although children with ADHD and multiple anxiety comorbidities were rated by their teachers as having more emotional problems (Strengths and Difficulties Questionnaire) in adjusted analyses (ES: 0.6). Poorer functioning was not observed for children with 1 anxiety comorbidity. On average, children with multiple anxiety comorbidities missed more school days (3.5 vs 2.1 days; P = .02), and tended to be late to school (3.9 vs 2.4 days; P = .08) more often than children without anxiety.
In adjusted analyses (Table 3), although the effect sizes attenuated, most findings maintained statistical significance. Children with multiple anxiety comorbidities still had poorer parent-reported QoL, behavior, and daily functioning. Children with multiple anxiety comorbidities tended to have more days missed (P = .07) or late for school (P = .06).
All results maintained statistical significance when additionally adjusting for parent mental health symptoms except for daily functioning (standardized mean difference: 0.2; 95% confidence interval –0.01 to 0.4; P = .06).
Association Between Anxiety and Functional Status by ADHD Presentation
Multiple anxiety comorbidities were associated with poorer QoL (ES: –0.9) and behavior (ES: 0.4) for children with ADHD-C, and poorer QoL (ES: –0.8), behavior (ES: 0.9), and daily functioning (ES: 0.7) for children with ADHD-I, in adjusted analyses (Table 4). The significance of the effects for child school attendance were not maintained in subgroup analyses. Although the association between anxiety and behavior and daily functioning appeared to be stronger for children with ADHD-I, there was not statistically significant evidence of a differential association for either outcome (behavior: P = .10; daily functioning: P = .22, tests of interaction).
This study examined the association between anxiety and functioning in children with ADHD. Anxiety was common, and multiple anxiety comorbidities were associated with poorer QoL and daily functioning, as well as more problematic behavior. There was limited evidence that anxiety exacerbated social difficulties. Multiple anxiety disorders were associated with poorer functioning for children with both ADHD-C and ADHD-I presentation.
The study strengths include the large sample, thorough assessment of ADHD and comorbidities, multi-informant data collection, and adjustment for variables that may have confounded the relationship between anxiety and function. To our knowledge, this is the first study to examine (1) how multiple anxiety comorbidities are associated with functioning in children with ADHD and (2) how anxiety affects the broader functioning (ie, QoL) of children with ADHD.
Anxiety was common in children with ADHD; 26% had 1 anxiety disorder, and 39% had ≥2 anxiety disorders. This appears higher than previous studies3 but is likely due to the inclusion of children with ASD. We argue that the inclusion of children with ASD reflects real-life clinical practice, especially in light of the fifth edition of the DSM, published in 2013, which permits the simultaneous diagnosis of these disorders.35 Multiple pathways may account for the overlap between ADHD and anxiety and have been outlined previously,3,22 including (1) anxiety developing secondary to ADHD in response to chronic failure, (2) ADHD symptoms being secondary to a primary anxiety disorder, (3) ADHD and anxiety arising due to separate etiologic pathways, and (4) comorbid anxiety and ADHD representing a separate, as yet unclassified disorder.
Previous research examining the association between anxiety and function in children with ADHD has used either a dimensional10 or a categorical approach14 in which children with ADHD and ≥1 anxiety disorders are compared with children with ADHD and no anxiety. Our study examined how screening positive for multiple anxiety disorders influences functioning. Children with multiple anxiety comorbidities were vulnerable to poorer functioning; however, children with 1 anxiety comorbidity were not. Thus the broader functioning of children with ADHD may only be compromised when a particularly high or pervasive level of anxiety is present. For example, greater levels of anxiety are likely associated with greater cognitive or executive functioning deficits and higher levels of avoidance and negative thought patterns, which in turn negatively influence daily functioning. It is also possible that a clinically significant anxiety phenotype is identified when children with ADHD are required to meet criteria for ≥2 anxiety disorders and that this approach avoids false positives.18 Multiple anxiety disorders were associated with poorer QoL and behavior for children with ADHD-C and poorer QoL, behavior, and daily functioning for children with ADHD-I. Although the effect sizes for the association between anxiety and behavior and daily functioning appeared stronger for children with ADHD-I compared with ADHD-C, this difference was not statistically significant.
We did not find evidence of an association between peer problems and anxiety. Although our findings are consistent with multiple studies,13,14,36 they are also in contrast to others.6,9,10 It is possible that our brief measure may not have been sensitive in detecting more subtle associations between social functioning and anxiety and that the use of observational methods or peer reports may have yielded different findings. Alternatively, our finding could be due to adjustment for externalizing, mood, and ASD comorbidities.
Consistent with previous research, children with anxiety and ADHD had parents with elevated mental health symptoms.22,23 The relationship between child anxiety and parental mental health is complex. Parental mental health difficulties may indicate that children with ADHD are vulnerable to environmental and familial stressors that could be manifested through anxiety.22 Parents may also experience heightened mental health symptoms due to challenges associated with their child’s behavior. This relationship could also reflect shared genetic vulnerabilities22 or the child modeling parental anxious behaviors. Even when taking into account parent mental health symptoms, we found that children with multiple anxiety disorders still had poorer QoL and behavior.
This study has some limitations. It was cross-sectional, and therefore longitudinal research is needed to examine how anxiety influences outcomes for children with ADHD overtime. Newcorn and colleagues did not find that anxiety predicted poorer outcomes for boys with ADHD (n = 32)37; however, research is needed using larger samples. Our sample consisted largely of males and families who were participating in studies examining sleep patterns; therefore, participants may have more comorbidities than the general ADHD population. Children with multiple anxiety disorders were more likely to have moderate/severe sleep problems. Anxiety is known to be a contributing factor to sleep problems in children38 and in turn, sleep problems may exacerbate daily functioning difficulties.32 We were unable to assess for ASD using a standardized measure; therefore, we relied on parent-reported diagnosis. Our findings should be replicated using child self-reports of anxiety given that anxiety was associated with poorer functioning by parent but not teacher report. However, teachers did observe children with parent-reported anxiety to have more emotional difficulties. Our teacher-report measures were brief, and the inclusion of more comprehensive measures (eg, academic functioning, self-esteem) may be more informative.
Although anxiety is common in children with ADHD, the influence of anxiety on the broader functioning of children with ADHD has been overlooked. Children with multiple anxiety comorbidities have substantially reduced QoL and poorer overall behavior and daily functioning. Systematically assessing and treating anxiety in children with ADHD has the potential to improve functioning for these children.
We thank all families, pediatricians, and teachers for taking part in the study, and all of the research assistants, students, and interns that contributed to data collection.
- Accepted February 20, 2014.
- Address correspondence to Emma Sciberras, DPsych, Centre for Community Child Health, Royal Children’s Hospital, Flemington Rd, Parkville 3052 Australia. E-mail:
Dr Sciberras coordinated the study and collected study data, conceptualized and designed the study, carried out the analyses, and drafted the initial manuscript; Ms Lycett coordinated the study and collected study data, contributed to the conception and design of the study, reviewed and revised the manuscript, and provided critical input; Drs Efron, Mensah, and Hiscock contributed to the conception and design of the study, reviewed and revised the manuscript, and provided critical input; Ms Gerner coordinated the study, collected study data, and contributed to the drafting of the manuscript; and all authors approved the final manuscript as submitted.
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: All aspects of the randomized controlled trial, including follow-up, were funded by a Project Grant from the Australian National Health and Medical Research Council (NHRMC; grant 607362). All aspects of the cohort study involving children with no/mild sleep problems were funded by Centre for Community Child Health at the Royal Children’s Hospital and the Murdoch Childrens Research Institute (MCRI). Dr Sciberras and Dr Mensah’s positions are funded by NHMRC Early Career Fellowships in Population Health (grants 1037159 and 1037449). Associate Professor Hiscock’s position is funded by an NHMRC Career Development Award (grant 607351). Ms Lycett is funded by the Hugh Rogers fund and an MCRI Postgraduate Health Scholarship. Dr Efron is funded by an MCRI Career Development Award. The MCRI is supported by the Victorian Government’s Operational Infrastructure Support Program.
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
- Copyright © 2014 by the American Academy of Pediatrics